Enhancement of GLP-2 activity of suppressing appetite
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 4, 2011
Grant Date -
Oct 7, 2004
app pub date -
Apr 22, 2004
filing date -
Feb 1, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The effects of GLP-2 are enhanced using a GLP-1 activity inhibitor. For medical use to treat or inhibit the onset of medical conditions, disorder or diseases for which treatment with GLP-2 is indicated, the present invention provides a pharmaceutical combination comprising a GLP-2 activity enhancer, and a GLP-1 activity inhibitor. The combination is useful particularly to treat gastrointestinal conditions such as small bowel syndrome, mucositis and Crohn's disease, and to suppress appetite, for instance to treat obesity.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully